MedTrace Logo

Stem Cell Derived Exome for Treatment of Diabetic Foot

NCT06480123 · Status: NOT_YET_RECRUITING · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2024-06-28

No results posted yet for this study

Summary

This trial is designed to investigate the safety and efficacy of patients with diabetic foot by using stem cell derived exome.

Conditions

  • Diabetic Foot
  • Stem Cell

Interventions

DRUG

Skin drug prepared with exome originated from stem cell

Skin drug prepared with exome originated from stem cell will be applied to patient with diabetic foot.

Sponsors & Collaborators

  • Second Affiliated Hospital of Guangzhou Medical University

    lead OTHER

Principal Investigators

  • Zhenfeng Zhang, MD, PhD · Second Affiliated Hospital of Guangzhou Medical University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-08-01
Primary Completion
2028-12-30
Completion
2033-12-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06480123 on ClinicalTrials.gov